arrow
G

Gilles Defer

Neurology
H指数:45
被引数:8,672

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study

在高危和低危侵袭性多发性硬化患者中保留神经功能:一项观察性队列研究

2026-04-040
OAAI
Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis

Rollot, F.; Casey, R.; Kerbrat, A.; Edan, G.; Le Page, E.; Vukusic, S.; Mathey, G.; Maillart, E.; De Sèze, J.; Ciron, J.; et al. 多发性硬化症中与复发和MRI活动无关的进展及治疗策略。Brain 2026, awag060. [Google Scholar] [CrossRef]

Brain
IF11.7
2026-04-010
PRE
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France
2025-10-270
PRE
LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in France
2025-02-190
OAAI
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies
2024-12-270
OA
Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France

法国多发性硬化症患者的教育水平与获得疾病改善治疗之间的关联

2024-12-010
PRE
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society
2024-02-152
PRE
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference
2023-03-216
OA
Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
2023-02-102
OAAI
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study
2023-01-015
OA
The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus

免疫重建疗法在法国复发性多发性硬化症治疗中的地位: 专家共识

2022-12-248
OAAI
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system
2022-12-143
PRE